Exploring the pathogenesis of necrotizing fasciitis due to streptococcus pneumoniae

Scandinavian Journal of Infectious Diseases

Volumn 34, Issue 9, 2002, Pages 639-644

  Kwak, Eun J ^a   McClure, Jo Ann ^a   McGeer, Allison ^a   Lee, B Craig ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CEFTRIAXONE; CLINDAMYCIN; DNA FRAGMENT; ERYTHROMYCIN; GENTAMICIN; HYDROCORTISONE; LEVOFLOXACIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; PROTEINASE; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CASE REPORT; CHRONIC DISEASE; CLINICAL FEATURE; COMORBIDITY; CYTOTOXICITY; DEATH; DEBRIDEMENT; DISEASE COURSE; ENZYME SYNTHESIS; FATALITY; FEMALE; HEMODIALYSIS; HIP DISEASE; HOST PATHOGEN INTERACTION; HUMAN; KIDNEY FAILURE; KNEE DISEASE; MALE; NECROTIZING FASCIITIS; PAIN ASSESSMENT; PATHOGENESIS; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SOFT TISSUE INFECTION; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PNEUMONIAE; TOXIC SHOCK SYNDROME; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; FASCIITIS, NECROTIZING; FATAL OUTCOME; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 0036386222     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540210147985     Document Type: Article

References (42)

1. Schuchar A, Robinson K, Wenger JD, Harrison LH, Farley M, Reingold AL, et al. Bacterial meningitis in the United States in 1995. N Engl J Med 1997; 337: 970-6.
2. Jacobs MR. Increasing importance of antibiotic-resistant Streptococcus pneumoniae in acute otitis media. Pediatr Infect Dis J 1996; 15: 940-3.
3. Marston BJ, Plouffe JF, File Jr TM, Hackman BA, Salstrom S-J, Lipman HB, et al. Incidence of community-acquired pneumonia requiring hospitalization: results of a population-based active surveillance study in Ohio. Arch Intern Med 1997; 157: 1709-18.
4. Robinson KA, Baughman W, Rothrock G, Barrett NL, Pass M, Lexau C, et al. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998. JAMA 1995; 285: 1729-35.
5. Austrian R, Gold J. Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. Ann Intern Med 1964; 60: 759-76.
6. Kramer MR, Rudensky B, Hadas-Halperin J, Isacsohn M, Melzer E. Pneumococcal bacteremia - no change in mortality in 30 years: analysis of 104 cases and review of the literature. Isr J Med Sci 1987; 23: 174-80.
7. Parada JP, Maslow JN. Clinical syndromes associated with adult pneumococcal cellulitis. Scand J Infect Dis 2000; 32: 133-6.
8. Hill MD, Karsh J. Invasive soft tissue infections with Streptococcus pneumoniae in patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1710-9.
9. Lawlor MT, Crowe HM, Quintiliani R. Cellulitis due to Streptococcus pneumoniae: case report and review. Clin Infect Dis 1992; 14: 247-50.
10. DiNubile MJ, Albornoz A, Myers AR, Stumacher RJ, Van Uitert BL, Paluzzi SA, et al. Pneumococcal soft tissue infections: possible association with connective tissue diseases. J Infect Dis 1991; 163: 897-900.
11. Patel M, Ahrens JC, Moyer DV, DiNubile MJ. Pneumococcal soft-tissue infections: a problem deserving more recognition. Clin Infect Dis 1994; 19: 149-51.
12. Choudhri SH, Brownstone R, Hashiem F, Magro CM, Crowson AN. A case of necrotizing fasciitis due to Streptococcus pneumoniae. Br J Dermatol 1995; 133: 128-31.
13. Baghai M, Osmon DR, Walk DM, Wold LE, Haidukewych GJ, Matteson EL. Fatal sepsis in a patient with rheumatoid arthritis treated with etanercept. Mayo Clin Proc 2001; 67: 653-6.
14. Frick S, Cerny A. Necrotizing fasciitis due to Streptococcus pneumoniae after intramuscular injection of nonsteroidal anti-inflammatory drugs: report of 2 cases and review. Clin Infect Dis 2001; 33: 740-4.
15. Ballon-Landa GR, Gherardi G, Beall B, Krosner S, Nizet V. Necrotizing fasciitis due to penicillin-resistant Streptococcus pneumoniae: case report and review of the literature. J Infect 2001; 42: 272-90.
16. McCormick JK, Schlievert PM. Toxins and superantigens of group A streptococci. In: Fischetti VA, Novick RP, Ferretti JJ, Portnoy DA, Rood JI, eds. Gram-positive pathogens, 1st edn. Washington DC: American Society for Microbiology, 2000: 43-52.
17. Kotb M. Bacterial pyrogenic exotoxins as superantigens. Clin Microbiol Rev 1995; 8: 411-26.
18. Ramotar K, Bobrowska M, Jessamine P, Toye B. Detection of methicillin-resistance in coagulase-negative staphylococci initially reported as methicillin susceptible using automated methods. Diagn Microbiol Infect Dis 1998; 30: 267-73.
19. Tyler AD, Johnson WM, Huang JC, Ashton FE, Wang G, Low DE, et al. Streptococcal erythrogenic toxin genes: detection by polymerase chain reaction and association with disease in strains isolated in Canada from 1940 to 1991. J Clin Microbiol 1992; 30: 3127-31.
20. Ubukata K, Asahi Y, Yamane A, Konna M. Combinational detection of autolysin and penicillin-binding protein 2b genes of Streptococcus pneumoniae by PCR. J Clin Microbiol 1996; 34: 592-6.
21. Chatelier S, Ihendyane N, Kansal RG, Khambaty F, Basma H, Norrby-Teglund A, et al. Genetic relatedness and super-antigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect Immun 2000; 68: 3523-34.
22. Ohman DE, Sadoff JC, Igelwski BH. Toxin A-deficient mutants of Pseudomonas aeruginosa PA103: isolation and characterization. Infect Immun 1980; 28: 899-908.
23. McKevitt AI, Woods DE. Characterization of Pseudomonas cepacia isolates from patients with cystic fibrosis. J Clin Microbiol 1984; 19: 291-3.
24. Sokol PA, Ohman DE, Iglewski BH. A more sensitive plate assay for detection of protease production by Pseudomonas aeruginosa. J Clin Microbiol 1979; 9: 538-40.
25. McCarthy AE, Victor G, Ramotar K, Toye B. Risk factors for acquiring ampicillin-resistant enterococci and clinical outcomes in a Canadian tertiary-care hospital. J Clin Microbiol 1994; 32: 2671-6.
26. Powell KR, Kaplan SB, Hall CB, Nasella MA, Roghmann KR. Peri-orbital cellulitis: clinical and laboratory findings in 146 episodes, including tear countercurrent immunoelectropheresis in 89 episodes. Am J Dis Child 1988; 142: 853-7.
27. Rimailho A, Riou B, Richard C, Auzepy P. Fulminant necrotizing fasciitis and nonsteroidal anti-inflammatory drugs. J Infect Dis 1987; 155: 143-6.
28. Smith RJ, Berk SL. Necrotizing fasciitis and nonsteroidal anti-inflammatory drugs. South Med J 1991; 84: 785-7.
29. Claverys J, Prudhomme M, Mortier-Barriere I, Martin B. Adaptation to the environment: Streptococcus pneumoniae, a paradigm for recombination-mediated genetic plasticity? Mol Microbiol 2000; 35: 251-9.
30. Dowson CG, Coffey TJ, Kell C, Whiley RA. Evolution of penicillin resistance in Streptococcus pneumoniae: the role of Streptococcus mitis in the formation of a low affinity PBP2b in S. pneumoniae. Mol Microbiol 1993; 9: 635-43.
31. Kaul R, McGeer A, Low D, Green K, Schwartz B, Simor A. Population-based surveillance for group A streptococcal necrotizing fasciitis: clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Am J Med 1997; 103: 18-24.
32. The Working Group on Severe Streptococcal Infections. Defining the group A streptococcal toxic shock syndrome: rationale and consensus definition. JAMA 1993; 369: 390-1.
33. Kaul R, McGeer A, Norrby-Teglund A, Koth M, Schwartz B, O'Rourke K, et al. Intravenous immunoglobulin therapy in streptococcal toxic shock syndrome: a comparative observational study. Clin Infect Dis 1999; 28: 800-7.
34. Whitney CG, Farley MM, Hadler J, Harrison LH, Lexau C, Reingold A, et al. Increasing prevalence of multidrug resistant Streptococcus pneumoniae in the United States. N Engl J Med 2000; 343: 1917-24.
35. Fiore AE, Moroney JF, Farley MM, Harrison LH, Patterson JE, Jorgensen JH, et al. Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance. Clin Infect Dis 2000; 30: 71-7.
36. Davies HD, McGeer A, Schwartz B, Green K, Cann D, Simor A, et al. Invasive group A streptococcal infections in Ontario, Canada. N Engl J Med 1996; 335: 547-54.
37. Nuorti JP, Butler JC, Crutcher JM, Guevara R, Welch D, Holter P, et al. An outbreak of multidrug resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents. N Engl J Med 1998; 338: 1861-8.
38. Kellner JD, Gibb AP, Zhang J, Rabin HR. Household transmission of Streptococcus pneumoniae, Alberta, Canada. Emerg Infect Dis 1999; 5: 154-8.
39. Gray BM, Converse GM, Dillon HC. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage and infection during the first 24 months of life. J Infect Dis 1980; 142: 923-33.
40. Craig AS, Erwin PC, Schaffner W, Elliott JA, Moore WL, Ussery XT, et al. Carriage of multidrug resistant Streptococcus pneumoniae and impact of chemoprophylaxis during an outbreak of meningitis at a day care center. Clin Infect Dis 1999; 29: 1257-64.
41. Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1997; 46: 1-24.
42. Dagan R, Muallem M, McIamed R, Leroy O, Yagupsky P. Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunity with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid. Pediatr Infect Dis J 1997; 16: 1060-4.